Baird Financial Group Inc. Sells 1,513 Shares of Masimo Co. (NASDAQ:MASI)

Baird Financial Group Inc. cut its holdings in shares of Masimo Co. (NASDAQ:MASIGet Rating) by 36.4% during the 2nd quarter, Holdings Channel reports. The firm owned 2,639 shares of the medical equipment provider’s stock after selling 1,513 shares during the period. Baird Financial Group Inc.’s holdings in Masimo were worth $345,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Bank of Nova Scotia increased its holdings in shares of Masimo by 19,378.7% during the second quarter. Bank of Nova Scotia now owns 305,037 shares of the medical equipment provider’s stock worth $39,859,000 after purchasing an additional 303,471 shares during the period. Texas Permanent School Fund increased its holdings in shares of Masimo by 2.5% during the second quarter. Texas Permanent School Fund now owns 36,908 shares of the medical equipment provider’s stock worth $4,823,000 after purchasing an additional 890 shares during the period. State of Michigan Retirement System increased its holdings in shares of Masimo by 0.8% during the second quarter. State of Michigan Retirement System now owns 12,996 shares of the medical equipment provider’s stock worth $1,698,000 after purchasing an additional 100 shares during the period. Meeder Asset Management Inc. increased its holdings in shares of Masimo by 61.3% during the second quarter. Meeder Asset Management Inc. now owns 221 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 84 shares during the period. Finally, Banque Pictet & Cie SA increased its holdings in shares of Masimo by 15.6% during the second quarter. Banque Pictet & Cie SA now owns 15,123 shares of the medical equipment provider’s stock worth $1,976,000 after purchasing an additional 2,037 shares during the period. 93.31% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on MASI shares. Jefferies Financial Group started coverage on shares of Masimo in a report on Wednesday, October 12th. They set a “buy” rating and a $180.00 target price on the stock. Stifel Nicolaus increased their price target on shares of Masimo from $162.00 to $172.00 and gave the stock a “buy” rating in a research report on Monday, September 12th. StockNews.com began coverage on shares of Masimo in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. Loop Capital began coverage on shares of Masimo in a research report on Tuesday, September 13th. They set a “buy” rating and a $206.00 price target on the stock. Finally, Piper Sandler reduced their price target on shares of Masimo from $150.00 to $135.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 9th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $190.29.

Insider Buying and Selling at Masimo

In related news, CEO Joe E. Kiani bought 31,994 shares of the business’s stock in a transaction on Monday, November 14th. The shares were purchased at an average price of $123.99 per share, for a total transaction of $3,966,936.06. Following the completion of the transaction, the chief executive officer now directly owns 39,778 shares of the company’s stock, valued at approximately $4,932,074.22. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CEO Joe E. Kiani bought 7,784 shares of the business’s stock in a transaction on Friday, November 11th. The shares were purchased at an average price of $129.27 per share, for a total transaction of $1,006,237.68. Following the completion of the transaction, the chief executive officer now directly owns 7,784 shares of the company’s stock, valued at approximately $1,006,237.68. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Joe E. Kiani bought 31,994 shares of the business’s stock in a transaction on Monday, November 14th. The stock was bought at an average price of $123.99 per share, for a total transaction of $3,966,936.06. Following the transaction, the chief executive officer now directly owns 39,778 shares of the company’s stock, valued at $4,932,074.22. The disclosure for this purchase can be found here. Company insiders own 9.70% of the company’s stock.

Masimo Stock Performance

Shares of Masimo stock opened at $142.03 on Wednesday. Masimo Co. has a fifty-two week low of $108.89 and a fifty-two week high of $299.78. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.12 and a quick ratio of 1.28. The firm has a market capitalization of $7.47 billion, a P/E ratio of 47.03 and a beta of 0.87. The company’s 50 day moving average price is $136.58 and its two-hundred day moving average price is $139.54.

Masimo Company Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Read More

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIGet Rating).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.